Key result
Pharmacists can minimize the risk of drug-induced QTc interval prolongation and torsades de pointes through knowledge of high-risk drugs, individualized risk assessment, and appropriate dose adjustments.
Design
Review
Authors
Loading...
May guide pharmacist QTc risk assessment in practice; leaves open effects on clinical events pending prospective trials.
This review highlights the risk factors, drug interactions, and management strategies for drug-induced QTc prolongation and torsades de pointes to guide clinical and pharmacy practice.
James E. Tisdale (2016) conducted a review in Drug-induced QT interval prolongation and torsades de pointes. Pharmacists can minimize the risk of drug-induced QTc interval prolongation and torsades de pointes through knowledge of high-risk drugs, individualized risk assessment, and appropriate dose adjustments.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: